These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9873481)

  • 1. SAR of novel biarylmethylamine dopamine D4 receptor ligands.
    Arlt M; Böttcher H; Riethmüller A; Schneider G; Bartoszyk GD; Greiner H; Seyfried CA
    Bioorg Med Chem Lett; 1998 Aug; 8(15):2033-8. PubMed ID: 9873481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.
    Thurkauf A; Chen X; Zhang S; Gao Y; Kieltyka A; Wasley JW; Brodbeck R; Greenlee W; Ganguly A; Zhao H
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2921-4. PubMed ID: 14611858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D(4) receptors.
    Hodgetts KJ; Kieltyka A; Brodbeck R; Tran JN; Wasley JW; Thurkauf A
    Bioorg Med Chem; 2001 Dec; 9(12):3207-13. PubMed ID: 11711296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new selective dopamine D4 receptor ligand.
    Sampson D; Zhu XY; Eyunni SV; Etukala JR; Ofori E; Bricker B; Lamango NS; Setola V; Roth BL; Ablordeppey SY
    Bioorg Med Chem; 2014 Jun; 22(12):3105-14. PubMed ID: 24800940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range.
    Abdel-Fattah MA; Lehmann J; Abadi AH
    Chem Biodivers; 2013 Dec; 10(12):2247-66. PubMed ID: 24327445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3143-6. PubMed ID: 10560741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand.
    Matulenko MA; Surber B; Fan L; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5095-8. PubMed ID: 15380206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
    Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.
    Zhao H; Thurkauf A; Braun J; Brodbeck R; Kieltyka A
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2119-22. PubMed ID: 10999484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands.
    Curtis NR; Kulagowski JJ; Leeson PD; Ridgill MP; Emms F; Freedman SB; Patel S; Patel S
    Bioorg Med Chem Lett; 1999 Feb; 9(4):585-8. PubMed ID: 10098669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J; Maeno K; Hidaka K; Nakato K; Matsumoto M; Tada S; Hattori H; Sakamoto S; Tsukamoto S; Usuda S; Mase T
    J Med Chem; 1996 Jul; 39(14):2764-72. PubMed ID: 8709107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
    Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
    Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).
    Löber S; Hübner H; Utz W; Gmeiner P
    J Med Chem; 2001 Aug; 44(17):2691-4. PubMed ID: 11495580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of QSAR in dopamine interactions.
    Hansch C; Verma RP; Kurup A; Mekapati SB
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2149-57. PubMed ID: 15808487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1969-72. PubMed ID: 10450964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
    Mansbach RS; Brooks EW; Sanner MA; Zorn SH
    Psychopharmacology (Berl); 1998 Jan; 135(2):194-200. PubMed ID: 9497025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.